C-CAR011

· Shanghai AbelZeta Ltd.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for C-CAR011, covering 2017-01-20 to 2019-01-17. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 1 Study Evaluating Safety and Efficacy of C-CAR011 Treatment in DLBCL Subjects [Phase 1]